Influenza Virus PB1 and Neuraminidase Gene Segments Can Cosegregate during Vaccine Reassortment Driven by Interactions in the PB1 Coding Region
暂无分享,去创建一个
[1] C. Isel,et al. A functional sequence-specific interaction between influenza A virus genomic RNA segments , 2013, Proceedings of the National Academy of Sciences.
[2] C. Isel,et al. Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses , 2013, Proceedings of the National Academy of Sciences.
[3] N. Heaton,et al. Colocalization of Different Influenza Viral RNA Segments in the Cytoplasm before Viral Budding as Shown by Single-molecule Sensitivity FISH Analysis , 2013, PLoS pathogens.
[4] S. Rockman,et al. The Source of the PB1 Gene in Influenza Vaccine Reassortants Selectively Alters the Hemagglutinin Content of the Resulting Seed Virus , 2013, Journal of Virology.
[5] C. Isel,et al. Interaction network linking the human H3N2 influenza A virus genomic RNA segments. , 2012, Vaccine.
[6] C. Isel,et al. An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus , 2012, Nucleic acids research.
[7] Kazuhiro Aoyama,et al. Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus , 2012, Nature Communications.
[8] C. Isel,et al. A supramolecular assembly formed by influenza A virus genomic RNA segments , 2011, Nucleic acids research.
[9] J. Gog,et al. Overlapping signals for translational regulation and packaging of influenza A virus segment 2 , 2011, Nucleic acids research.
[10] D. Bucher,et al. Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production , 2011, PloS one.
[11] B. Lina,et al. Genetic content of Influenza H3N2 vaccine seeds , 2010, PLoS currents.
[12] Gavin J. D. Smith,et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.
[13] Wendy S. Barclay,et al. A Complicated Message: Identification of a Novel PB1-Related Protein Translated from Influenza A Virus Segment 2 mRNA , 2009, Journal of Virology.
[14] H. Ly,et al. Mutational Analyses of Packaging Signals in Influenza Virus PA, PB1, and PB2 Genomic RNA Segments , 2007, Journal of Virology.
[15] Kelli L Boyd,et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.
[16] Yukiko Muramoto,et al. Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions , 2006, Journal of Virology.
[17] Yuying Liang,et al. cis-Acting Packaging Signals in the Influenza Virus PB1, PB2, and PA Genomic RNA Segments , 2005, Journal of Virology.
[18] C. Gerdil. The annual production cycle for influenza vaccine. , 2003, Vaccine.
[19] W. Greene,et al. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.
[20] Jonathan W. Yewdell,et al. A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.
[21] R. Webster,et al. A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Webster,et al. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics , 1989, Journal of virology.
[23] G. Tannock,et al. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens , 1984, Infection and immunity.
[24] C. Scholtissek,et al. On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.
[25] E. D. Kilbourne,et al. Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. , 1960 .
[26] E. D. Kilbourne. Future influenza vaccines and the use of genetic recombinants. , 1969, Bulletin of the World Health Organization.